During the past decade, UMHAT "Kaspela", EOOD conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 32 clinical trials were completed, i.e. on average, 82.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 23 clinical trials were completed. i.e. 766.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMHAT "Kaspela", EOOD" #1 sponsor was "Pfizer" with 10 trials, followed by "Galapagos NV" with 7 trials sponsored, "Allergan" with 4 trials sponsored, "Celgene" with 4 trials sponsored and "Boehringer Ingelheim" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMHAT "Kaspela", EOOD" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "OCT Clinical Trials" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Centessa Pharmaceuticals plc" with 1 trials as a collaborator and "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "UMHAT "Kaspela", EOOD" are "Rheumatoid Arthritis" (14 trials), "Gastroparesis" (4 trials), "Psoriatic Arthritis" (4 trials), "Ulcerative Colitis" (4 trials) and "Ankylosing Spondylitis" (3 trials). Many other conditions were trialed in "UMHAT "Kaspela", EOOD" in a lesser frequency.

Most popular intervention types in "UMHAT "Kaspela", EOOD" are "Drug" (40 trials), "Biological" (4 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Adalimumab" (3 trials), "Relamorelin" (3 trials), "filgotinib" (3 trials) and "BI 695501" (2 trials). Other intervention names were less common.

The vast majority of trials in "UMHAT "Kaspela", EOOD" are 43 trials for "All" genders.

Currently, there are NaN active trials in "UMHAT "Kaspela", EOOD". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in UMHAT "Kaspela", EOOD, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in UMHAT "Kaspela", EOOD, 0 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".